東方財富(300059.SZ)擬發行不超158億元可轉債 用於補充東方財富證券營運資金等
格隆匯10月21日丨東方財富(300059.SZ)披露向不特定對象發行可轉換公司債券預案,公司擬向不特定對象發行總額不超過人民幣158億元(含)可轉換公司債券,可轉債期限為發行之日起六年;此次可轉債的初始轉股價格不低於募集説明書公告日前20個交易日公司股票交易均價。
募資淨額將用於補充公司全資子公司東方財富證券的營運資金,支持其各項業務發展,增強其抗風險能力;在可轉債轉股後按照相關監管要求用於補充東方財富證券的資本金,以擴展業務規模,優化業務結構,提高其綜合競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.